Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

AGA Creates Center for Gut Microbiome Research and Education

Published: Thursday, March 14, 2013
Last Updated: Monday, March 25, 2013
Bookmark and Share
Recognizing the major influence the gut microbiome is likely to have on the future of digestive disease research and patient care.

In a healthy adult, microbial cells are estimated to outnumber human cells 10 to one. Many microbes maintain our health, while others cause illness. Recent investigations of the human gut microbiome have discovered important ways in which gut microbes may influence a number of important disease states including obesity, inflammatory bowel disease, functional gastrointestinal disorders, cancers and liver disease. The AGA Governing Board is pleased to announce the creation of the AGA Center for Gut Microbiome Research and Education.

“The gut microbiome is among the most exciting and promising areas of research today. As gastroenterologists, we are in an excellent position to perform gut microbiome research and translate basic discoveries into new methods to maintain and improve the health of our patients,” said Loren Laine, MD, AGAF, president of the AGA Institute. “The gut microbiome offers a myriad of possibilities to GI basic and translational researchers, clinicians and patients.” 

 The AGA Center for Microbiome Research and Education will be a virtual “home” for the AGA’s activities related to the gut microbiome. The mission of the center is “To advance research and education on the gut microbiome in human health and disease.”

 To provide guidance on gut microbiome-related issues, the AGA has convened a scientific advisory board comprised of world leaders in computational biology and metagenomics, microbiome animal models, microbiology translational research, nutrition, and pertinent regulatory and policy issues. These advisors will make strategic and programmatic recommendations to the AGA Governing Board.

 “This is an incredibly exciting time in science, where technological advances in DNA sequencing, transcriptomics, proteomics and metabolomics provide an unprecedented opportunity to explore not only the composition, but also the function of the microbial communities that live in our intestinal tract. It is hoped that the knowledge gained will provide new insights into disease pathogenesis and innovative therapeutic modalities. The membership of the AGA is ideally suited to translate these findings from the bench to the bedside,” says Gary Wu, MD, chair of the scientific advisory board.  

 Scientific advisory board members:

Gary D. Wu, MD, chair

Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Martin J. Blaser, MD

George and Muriel Singer Professor of Medicine, Professor of Microbiology and Director, Human Microbiome Program at the New York University Langone Medical Center, New York

Jeffrey I. Gordon, MD, AGAF 

Dr. Robert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences & Systems Biology at Washington University, St. Louis, MO

Gail Hecht, MD, MS, AGAF

Professor of Medicine, Microbiology/Immunology and Chief, Gastroenterology and Nutrition at Loyola University Medical Center, Maywood, IL

Lee M. Kaplan, MD, PhD, AGAF

Director, Obesity, Metabolism & Nutrition Institute, Gastrointestinal Unit at Massachusetts General Hospital, Boston

Rob Knight, PhD

Associate Professor, University of Colorado, Boulder

Mary Ellen Sanders, PhD

Executive Director of the International Scientific Association for Probiotics and Prebiotics, Centennial, CO  

Ryan Balfour Sartor, MD

Distinguished Professor, Medicine, Microbiology and Immunology at the University of North Carolina - Chapel Hill

Richard M. Peek, Jr., MD, AGAF, ex-officio

Chairman, Division of Gastroenterology, Hepatology & Nutrition at Vanderbilt University School of Medicine, Nashville

Vincent W. Yang, MD, PhD, ex-officio

Professor and Chair of Medicine, Stony Brook University School of Medicine, NY

The AGA will fund the center’s activities and will seek funds from private, non-profit and governmental sources to help support the center. 

Danone is a founding supporter of the center.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos